Latest Tomotherapy Stories
SUNNYVALE, Calif., Oct. 24, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that it will report results for its first quarter of fiscal year 2012, ended September 30, 2011 on Tuesday, November 8, 2011 after the market closes. A conference call to review the results of its first quarter of fiscal year 2012 will begin at 2:00 p.m. PST/5:00 p.m. EST and will be hosted by Euan S. Thomson, Ph.D., president and chief executive...
SUNNYVALE, Calif., Oct. 19, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that it ranked 274th on Deloitte's Technology Fast 500(TM) ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2006 to 2010; during this period, Accuray grew 319...
Prostate cancer is the most common cancer in men in the United States, as well as the second leading cause of cancer-related deaths in this population. Many of these patients undergo surgical removal of their prostate, followed by radiation therapy applied to their prostate bed — the space where the prostate was once situated. The most common technique of post-prostatectomy radiation is Intensity Modulated Radiation Therapy (IMRT), in which radiation beams closely conform to the area of...
MIAMI and SUNNYVALE, Calif., Oct. 3, 2011 /PRNewswire/ -- American Society for Radiation Oncology (ASTRO) 53(rd) Annual Meeting --Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that the company is unveiling several enhancements to its CyberKnife® Robotic Radiosurgery System and TomoTherapy® Radiation Therapy System as well as rolling out its Diamond Plus Service Program to TomoTherapy customers* at The American Society for Radiation...
SUNNYVALE, Calif., Sept. 26, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the JMP Securities Healthcare Conference in New York on Wednesday, September 28, 2011 at 9:30 a.m. EDT/6:30 a.m. PDT. A live webcast of the presentation will be available online from the investor relations page of the Company's website at http://www.accuray.com. The webcast replay of the presentation...
SUNNYVALE, Calif., Sept. 23, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced details of the 2011 International Conference on TomoTherapy (ICT), which took place September 16-17, 2011 hosted by the University of Heidelberg, Germany's oldest University and world famous research center for cancer and microbiology. University of Heidelberg was the first institution in Germany to adopt the TomoTherapy® System for daily...
SUNNYVALE, Calif., Sept. 21, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that Kelly Londy has joined Accuray as Senior Vice President and Chief Commercial Officer, effective October 1, 2011. Londy has spent her career working in the medical device field, serving in leadership roles for major medical capital equipment companies General Electric (GE) Healthcare and Philips Healthcare. She brings more than 20 years of...
SUNNYVALE, Calif., Sept. 19, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today financial results for the fourth quarter and fiscal year ended June 30, 2011. It should be noted that the acquisition of TomoTherapy was completed on June 10, 2011. As a result, fourth quarter and fiscal 2011 financial data presented reflect the addition of TomoTherapy results from June 10, 2011 through June 30, 2011. Backlog, shipments and...
SUNNYVALE, Calif., Sept. 16, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the UBS Global Life Sciences Conference in New York on Tuesday, September 20, 2011 at 4:30 p.m. ET/1:30 p.m. PT. A live webcast of the presentation will be available online from the investor relations page of the Company's Web site at http://www.accuray.com. The webcast replay of the presentation will...
SUNNYVALE, Calif., Sept. 13, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), today announced that it will report results for its fourth quarter and fiscal year 2011, ended June 30, 2011 on Monday, September 19, 2011 after the market closes. The Company filed with the United States Securities and Exchange Commission, Form 12b-25 Notification of Late Filing to extend the time allowed for filing its Form 10-K for the period ended June 30, 2011. The late filing is the result of the...
